Pancreatic cancer: Update on immunotherapies and algenpantucel-L.

about

Stratification of Pancreatic Ductal Adenocarcinoma: Combinatorial Genetic, Stromal, and Immunologic Markers.Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression.

P2860

Q38872869-C088CE02-2387-4F0B-A912-955FD3F82659 Q46014755-1BCC85AE-8206-4360-AD0E-93BC242CFF67

P2860

Pancreatic cancer: Update on immunotherapies and algenpantucel-L.

Item

http://www.wikidata.org/entity/Q40261599

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Pancreatic cancer: Update on immunotherapies and algenpantucel-L.

@en

type

Item

label

Pancreatic cancer: Update on immunotherapies and algenpantucel-L.

@en

prefLabel

Pancreatic cancer: Update on immunotherapies and algenpantucel-L.

@en

P1476

Pancreatic cancer: Update on immunotherapies and algenpantucel-L.

@en

P2093

Andrew L Coveler

http://www.w3.org/2001/XMLSchema#string

Charles Link

http://www.w3.org/2001/XMLSchema#string

E Gabriela Chiorean

http://www.w3.org/2001/XMLSchema#string

Gabriela R Rossi

http://www.w3.org/2001/XMLSchema#string

Kinsey A McCormick

http://www.w3.org/2001/XMLSchema#string

Nicholas N Vahanian

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of allogeneic fetal rejection by tryptophan catabolism

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: A dose escalating phase I/II study

Pathways for aberrant angiogenesis in pancreatic cancer

Cancer statistics, 2015

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Pancreatic cancer, treatment options, and GI-4000

Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation

Calreticulin exposure dictates the immunogenicity of cancer cell death

The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance

P304

563-575

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2015.1093264

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26619245

http://www.w3.org/2001/XMLSchema#string

P932

4964650

http://www.w3.org/2001/XMLSchema#string

Pancreatic cancer: Update on immunotherapies and algenpantucel-L.

about

P2860

P2860

Pancreatic cancer: Update on immunotherapies and algenpantucel-L.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932